Literature DB >> 16449235

Impaired helix 12 dynamics due to proline 892 substitutions in the androgen receptor are associated with complete androgen insensitivity.

Youssef A Elhaji1, Ileana Stoica, Sheldon Dennis, Enrico O Purisima, Rose Lumbroso, Lenore K Beitel, Mark A Trifiro.   

Abstract

Structural studies of the ligand-binding domain (LBD) of several steroid receptors have revealed that the dynamic properties of the C-terminal helix 12 (H12) are the major determinant of the activation mode of these receptors. H12 exhibits high mobility and different conformations in the absence of ligand. Upon ligand binding, H12 is stabilized in a precise position to seal the ligand-binding pocket and finalize the assembly of the activation function (AF-2) domain. In this study, we investigated the role of the conserved proline 892 of the androgen receptor (AR) in directing the dynamic location and orientation of the AR-H12. We used a combined approach including kinetic and biochemical assays with molecular dynamic simulations to analyze two substitutions (P892A and P892L) identified in individuals with complete androgen insensitivity syndrome. Our analyses revealed distinct mechanisms by which these substitutions impair H12 function resulting in severely defective receptors. The AR-P892A receptor exhibited reduced ligand binding and transactivational potential because of an increased flexibility in H12. The AR-P892L substitution renders the receptor inactive due to a distorted, unstructured and misplaced H12. To confirm the mutants' inability to stabilize H12 in an active position, we have developed a novel in vivo assay to evaluate the accessibility of the H12-docking site on the AR-LBD surface. An extrinsic AR-H12 peptide was able to interact with wild-type and mutant LBDs in the absence of ligand. Ligand-induced proper positioning of the intrinsic H12 of wild-type AR prevented these interactions, whereas the misplacement of the mutants' H12 did not. Proline at this position may be critical for H12 dynamics not only in the AR, but also in other nuclear receptors where this proline is conserved.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16449235     DOI: 10.1093/hmg/ddl009

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  8 in total

1.  Mechanism of androgen receptor antagonism by bicalutamide in the treatment of prostate cancer.

Authors:  D J Osguthorpe; A T Hagler
Journal:  Biochemistry       Date:  2011-04-25       Impact factor: 3.162

2.  Analysis of agonist and antagonist effects on thyroid hormone receptor conformation by hydrogen/deuterium exchange.

Authors:  A C M Figueira; D M Saidemberg; P C T Souza; L Martínez; T S Scanlan; J D Baxter; M S Skaf; M S Palma; P Webb; I Polikarpov
Journal:  Mol Endocrinol       Date:  2010-11-24

3.  Synthesis and structure-activity relationship studies of novel dihydropyridones as androgen receptor modulators.

Authors:  Antonella Pepe; Michael Pamment; Yeong Sang Kim; Sunmin Lee; Min-Jung Lee; Kristin Beebe; Anton Filikov; Len Neckers; Jane B Trepel; Sanjay V Malhotra
Journal:  J Med Chem       Date:  2013-10-30       Impact factor: 7.446

4.  The helix 1-3 loop in the glucocorticoid receptor LBD is a regulatory element for FKBP cochaperones.

Authors:  Carmel Cluning; Bryan K Ward; Sarah L Rea; Ajanthy Arulpragasam; Peter J Fuller; Thomas Ratajczak
Journal:  Mol Endocrinol       Date:  2013-05-17

Review 5.  Understanding nuclear receptors using computational methods.

Authors:  Ni Ai; Matthew D Krasowski; William J Welsh; Sean Ekins
Journal:  Drug Discov Today       Date:  2009-03-11       Impact factor: 7.851

6.  Molecular Dynamics Simulations Revealed the Regulation of Ligands to the Interactions between Androgen Receptor and Its Coactivator.

Authors:  Na Liu; Wenfang Zhou; Yue Guo; Junmei Wang; Weitao Fu; Huiyong Sun; Dan Li; Mojie Duan; Tingjun Hou
Journal:  J Chem Inf Model       Date:  2018-07-20       Impact factor: 4.956

7.  Severe forms of partial androgen insensitivity syndrome due to p.L830F novel mutation in androgen receptor gene in a Brazilian family.

Authors:  Reginaldo J Petroli; Andréa T Maciel-Guerra; Fernanda C Soardi; Flávia L de Calais; Gil Guerra-Junior; Maricilda Palandi de Mello
Journal:  BMC Res Notes       Date:  2011-06-06

8.  Active nuclear receptors exhibit highly correlated AF-2 domain motions.

Authors:  Denise G Teotico; Monica L Frazier; Feng Ding; Nikolay V Dokholyan; Brenda R S Temple; Matthew R Redinbo
Journal:  PLoS Comput Biol       Date:  2008-07-11       Impact factor: 4.475

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.